Danish CNS specialist Lundbeck announced the full results from the Phase IV RESOLUTION trial at the 11th Congress of the ...

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has pointed to the role that it has played over ...

Swiss drugmaker Idorsia today announced that Simcere Pharmaceuticals (HK: 2096) has received approval for Quviviq ...

US drugmaker Vertex Pharmaceuticals has announced simultaneous presentation and publication of updated data from the Phase ...

Swiss pharma giant Roche has released encouraging results from the Phase III SUNMO study showing Lunsumio (mosunetuzumab) administered subcutaneously in combination with Polivy (polatuzumab vedotin), ...

Geopolitics, medicines and European legislation – it all came together during a special AXON-Bruggink session on the position of the Netherlands as a location for innovative medicines, according to ...

Danish drugmaker Novo Nordisk has released fresh clinical data on two of its lead investigational assets, seeking to bolster ...

In June 2025, Cycle received FDA approval for HARLIKU (nitisinone) tablets for alkaptonuria (AKU), a rare metabolic disorder ...

Armed with an asset that could be an improvement on Pfizer’s blockbuster smoking cessation drug Chantix/Champix (varenicline) ...

Notable research news last week included Sarepta Therapeutics reporting another death associated with a trial of its Duchenne ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hetronifly (serplulimab) to treat adults ...

At a time when Novo Nordisk has appeared to be slipping behind rival Eli Lilly and its blockbuster Zepbound (tirzepatide) in ...